Concurrent use of omalizumab and dupilumab in a 47-year-old woman with chronic spontaneous urticaria and atopic dermatitis

Jesper Grønlund Holm^*, Jennifer Astrup Sørensen, Simon Francis Thomsen

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	International Journal of Dermatology
Vol/bind	61
Udgave nummer	5
Sider (fra-til)	e173-e174
ISSN	0011-9059
DOI	https://doi.org/10.1111/ijd.16009
Status	Udgivet - 2022

Adgang til dokumentet

@article{ff59a9dd66314f4c8b71b917808ef67f,

title = "Concurrent use of omalizumab and dupilumab in a 47-year-old woman with chronic spontaneous urticaria and atopic dermatitis",

author = "Holm, {Jesper Gr{\o}nlund} and S{\o}rensen, {Jennifer Astrup} and Thomsen, {Simon Francis}",

year = "2022",

doi = "10.1111/ijd.16009",

language = "English",

volume = "61",

pages = "e173--e174",

journal = "International Journal of Dermatology",

issn = "0011-9059",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Concurrent use of omalizumab and dupilumab in a 47-year-old woman with chronic spontaneous urticaria and atopic dermatitis

AU - Holm, Jesper Grønlund

AU - Sørensen, Jennifer Astrup

AU - Thomsen, Simon Francis

PY - 2022

Y1 - 2022

U2 - 10.1111/ijd.16009

DO - 10.1111/ijd.16009

M3 - Comment/debate

C2 - 34813086

AN - SCOPUS:85119653632

VL - 61

SP - e173-e174

JO - International Journal of Dermatology

JF - International Journal of Dermatology

SN - 0011-9059

IS - 5

ER -